Serum M30 levels are associated with survival in advanced gastric carcinoma patients.

Yaman E, Coskun U, Sancak B, Buyukberber S, Ozturk B, Benekli M.

Serum M30 levels are associated with survival in advanced gastric carcinoma patients. Int Immunopharmacol.

2010 Jul;10(7):719-22. doi: 10.1016/j.intimp.2010.03.013. Epub 2010 Mar 31. PubMed PMID: 20362077.

İlgili Makaleler

Serum and ascitic fluid nitrate levels in patients with cirrhosis.

Ekim 21, 2020

Prognostic importance of tumor angiogenesis in breast carcinoma with adjuvant chemotherapy. 

Ekim 21, 2020

A case of Sweet’s syndrome developed after the treatment of herpes simplex infection in a metastatic breast cancer patient.

Ekim 21, 2020

Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients.

Ekim 21, 2020

Bir yanıt yazın

E-posta adresiniz yayınlanmayacak. Gerekli alanlar * ile işaretlenmişlerdir

Başa dön tuşu
Call Now Button0312 229 20 55